Incyte (INCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY)

INCY 102.67

+2.5%

Feb 2 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Larry Liebman who wrote (518)	10/22/1997 4:33:00 PM
From: Joseph wang	Read Replies (1) of 3202

<< I spoke with the company last week and they are indeed looking at capturing the business of smaller pharma and biotechs. >> that may not be easy to do, considering their subscription charges are not cheap (I have estimated figures of about $6-8 Million / year). Most smaller pharm's and biotechs can't afford to spend that kind of money on this new technology. Big pharms have speculatively dropped loads of money into bioinformatics in hopes that new drugs will be developed. As for the usefulness of LifeSeq, we'll only be able to tell when one of the pharms announces a Phase I clinical trial based on assistance from LifeSeq...that would be hard proof (and it would drive the stock up incredibly high!!) -JW

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next